Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo
Research use only24h dispatchLot-tracked COA

VaultLabs UAE

Tirzepatide in Dubai and the UAE

Tirzepatide 30mg is one of four incretin-class lines in the catalogue, and it shares its nominal fill mass with a second one. That single coincidence — 30 mg on both this line and Semaglutide 30mg — accounts for most receiving errors involving it. This page covers what the SKU is, which fields on a certificate actually separate these materials, and how to order and receive the unit in the UAE. Sequence and registry data belong to the tirzepatide monograph. Supplied for in vitro laboratory research only.

Featured materials

In the catalogue

Third-party testedVaultLabs tested · 99.91%

Tested before release

Each catalogue batch is tested by an independent laboratory before release, then checked again on the VaultLabs certificate. The laboratory report for this lot is available on request, and the laboratory is named on that report.

Lot VL-TIRZ-20260801 · 99.91%

Four catalogue lines, two identical fill masses

The incretin-class lines are tirzepatide at 30 mg, semaglutide at 30 mg, GLP-3 RT 10mg (Reta) at 5, 10, 15, 20, 30, and 100 mg, and the RETA/CAG blend at 15 mg. Two of them are indistinguishable by nominal mass, all of them arrive as white to off-white lyophilised cakes, and none of them shares lots or certificates with the others.

A requisition that reads GLP peptide 30mg is therefore not an order, it is a guess. Name the catalogue SKU in full on the purchase order, on the inventory row and in the notebook entry, and keep the four lines on four rows. Catalogue relationships are set out in the semaglutide and tirzepatide comparison and the retatrutide and tirzepatide comparison.

The identity fields that do the work

Tirzepatide is catalogued under CAS 2023788-19-2 with molecular formula C225H348N48O68 and a molecular weight of 4813.53 g/mol. Semaglutide's registry number is different and its molecular weight is roughly 700 daltons lower, so where a record prints formula and mass those fields separate the two unambiguously — which the strength field cannot do.

Build the receiving check around that. Match compound name, registry number and, where printed, molecular formula against the published record before the unit leaves quarantine, and note whether the analysis is described as independent or supplier-generated. The COA interpretation guide covers field-by-field review and the receiving checklist makes it a signable step.

Documentation and the reorder record

Per-lot certificates are published to batch verification once uploaded, and the tirzepatide COA index reaches the same records from the product page. Where a lot has no published document yet, raise a documentation request with the lot and order reference and hold the unit rather than accepting an adjacent lot's paperwork.

For work that spans several orders, record the catalogue SKU and the lot on every entry. Reordering keeps the SKU stable while the lot changes with inventory, and that change is the thing your records exist to capture. Requirements beyond standard checkout, including repeat institutional volume, go through wholesale procurement.

Storage, dispatch and scope

Sealed vials are held cold and protected from light and moisture per the printed label and lot record. Dubai orders dispatch from Dubai to all seven emirates, with AED pricing at checkout; log the lot and time of receipt and move the parcel into cold storage before the paperwork is closed out, which in Gulf summer months is the handling step that matters most. Site policy sits in the research peptide storage guide.

This material is a reference reagent supplied for in vitro laboratory research only. VaultLabs makes no statements about metabolic, weight-related or physiological effects, supplies nothing for human or animal use, personal use or medical application, and provides no administration or preparation guidance for living systems. Buyer obligations are set out in the research use policy.

Frequently asked questions

One sealed vial at a nominal 30 mg fill of white to off-white lyophilised powder, labelled with catalogue name, strength and lot identifier. No diluent is included and there is no second strength in this line.

By identity fields rather than mass: both lines carry a nominal 30 mg fill, so use the compound name, registry number and printed molecular formula or weight on the published record for the lot.

No. Tirzepatide, semaglutide, the GLP-3 RT strengths and the RETA/CAG blend all hold independent lots and independent records. None can be used to release another.

No. It is supplied for in vitro laboratory research under institutional oversight. VaultLabs makes no claims of any kind about effects in living systems and provides no administration guidance.

Yes. The catalogue line is the 30 mg lyophilised vial. Checkout is in AED and the parcel leaves Dubai for the other emirates. It is not the semaglutide 30 mg vial.

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.